Inflammatory breast cancer is treated similarly to locally advanced breast cancer, with initial chemotherapy including anthracycline and taxane, plus trastuzumab and pertuzumab if HER2 positive. The response is then checked, and if positive, mastectomy and clearance is followed by radiation and reconstruction before adjuvant therapy including completing chemotherapy, and hormone therapy if receptors are positive, as well as trastuzumab and pertuzumab for one year. If no initial response, additional chemotherapy and radiation is considered.
Inflammatory breast cancer is treated similarly to locally advanced breast cancer, with initial chemotherapy including anthracycline and taxane, plus trastuzumab and pertuzumab if HER2 positive. The response is then checked, and if positive, mastectomy and clearance is followed by radiation and reconstruction before adjuvant therapy including completing chemotherapy, and hormone therapy if receptors are positive, as well as trastuzumab and pertuzumab for one year. If no initial response, additional chemotherapy and radiation is considered.
Inflammatory breast cancer is treated similarly to locally advanced breast cancer, with initial chemotherapy including anthracycline and taxane, plus trastuzumab and pertuzumab if HER2 positive. The response is then checked, and if positive, mastectomy and clearance is followed by radiation and reconstruction before adjuvant therapy including completing chemotherapy, and hormone therapy if receptors are positive, as well as trastuzumab and pertuzumab for one year. If no initial response, additional chemotherapy and radiation is considered.
• Same as Locally advanced breast cancer management
• Same work up • Initial management is with chemotherapy ◦ Antrhacycline + Taxane preferred ◦ If HER2 positive → Trastuzumab + Pertuzumab both should ideally be given • Check response • If responded ◦ Mastectomy + Axillary clearance ◦ Followed by radiation to chest wall, supraclavicular area + internal mammary nodes if they are involved ◦ Delayed breast reconstruction ◦ Then proceed to adjuvant ‣ Complete planned chemotherapy regimen ‣ Endocrine therapy if ER/PR +ve to be given sequentially after CT is over ‣ Trastuzumab + Pertuzumab to be completed for a period of 1 year • If no response ◦ Consider addition chemo + RT ◦ If responded → above management ◦ If no response → individualized management